What is the 13F Pro Quality Score for AMS?

13F Pro ranks AMERICAN SHARED HOSPITAL SERVICES (AMS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View AMS's current score at https://13fpro.ai/research/AMS (free sign-up required for the full ranking).

Where does 13F Pro source AMS data?

All AMERICAN SHARED HOSPITAL SERVICES fundamentals and ownership data come directly from SEC EDGAR. AMERICAN SHARED HOSPITAL SERVICES files with the SEC under CIK 744825. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is AMS in?

AMERICAN SHARED HOSPITAL SERVICES (AMS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is AMS research updated on 13F Pro?

AMS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

AMERICAN SHARED HOSPITAL SERVICES(AMS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 744825 AMS stock profile & AI dashboard →

13F Pro Quality Score

33.7/100

Rank #2,223 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

74.2/100

Profitability

22.1/100

Balance Sheet

27.8/100

Earnings Quality

30.0/100

Free Cash Flow

16.6/100

Institutional Flow

58.6/100

Revenue Scale

6.6/100

Dilution Risk

48.1/100

AMS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for AMERICAN SHARED HOSPITAL SERVICES (AMS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AMS at 33.7/100 on a 32-signal composite quality model, placing it at rank #2,223 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (6.6) and free cash flow (16.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 48.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), AMERICAN SHARED HOSPITAL SERVICES reports quarterly revenue of $7.1M, net income of $-612.0K, an operating margin of -13.0%. Top institutional holders of AMS by reported 13-F value include DIMENSIONAL FUND ADVISORS, Corient Private Wealth, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AMS trades on the NYSE exchange and files with the SEC under CIK 744825. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMERICAN SHARED HOSPITAL SERVICES directly from SEC EDGAR. AMERICAN SHARED HOSPITAL SERVICES's 13F Pro composite quality score has ranged between 34 and 51 since 2025, currently 33.7 — a declining long-term trajectory across 11 quarterly and live scoring snapshots.

Revenue

Q1 2026

$7.1M

Net Income

Q1 2026

$-612.0K

Free Cash Flow

Q1 2026

$2.1M

Operating Margin

Q1 2026

-13.0%

ROIC

Q1 2026

-2.3%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+42.2% YoY

$28.1MFY 2025

FY18 $19.7MFY20 $17.8MFY22 $19.7MFY25 $28.1M

Net Income

-216.9% YoY

$-1.6MFY 2025

FY18 $1.0MFY20 $-7.1MFY22 $1.3MFY25 $-1.6M

Operating Income

-247.6% YoY

$-3.6MFY 2025

FY18 $1.9MFY20 $-9.5MFY22 $2.4MFY25 $-3.6M

EPS (Diluted)

-209.5% YoY

$-0.23FY 2025

FY18 $0.17FY20 $-1.14FY22 $0.21FY25 $-0.23

Total Assets

+26.2% YoY

$55.5MFY 2025

FY18 $57.5MFY20 $43.7MFY22 $44.0MFY25 $55.5M

Total Debt

+132.4% YoY

$34.7MFY 2025

FY18 $7.6MFY20 $6.3MFY22 $14.9MFY25 $34.7M

Op. Cash Flow

-57.2% YoY

$3.1MFY 2025

FY18 $8.1MFY20 $9.7MFY22 $7.2MFY25 $3.1M

Metric	FY 2025	FY 2022	FY 2020	FY 2018	FY 2017	FY 2016
Revenue	$28.1M +42.2%	$19.7M +10.7%	$17.8M -9.5%	$19.7M +0.8%	$19.6M +4.6%	$18.7M
Net Income	$-1.6M -216.9%	$1.3M +118.8%	$-7.1M -789.9%	$1.0M -46.8%	$1.9M +106.8%	$930.0K
Operating Income	$-3.6M -247.6%	$2.4M +125.7%	$-9.5M -608.5%	$1.9M -22.9%	$2.4M -26.6%	$3.3M
EPS (Diluted)	$-0.23 -209.5%	$0.21 +118.4%	$-1.14 -770.6%	$0.17 -48.5%	$0.33 +94.1%	$0.17
Total Assets	$55.5M +26.2%	$44.0M +0.7%	$43.7M -24.1%	$57.5M -1.2%	$58.2M -4.0%	$60.6M
Total Debt	$34.7M +132.4%	$14.9M +138.8%	$6.3M -17.4%	$7.6M -11.1%	$8.5M -10.5%	$9.5M
Operating Cash Flow	$3.1M -57.2%	$7.2M -25.8%	$9.7M +20.9%	$8.1M +2.7%	$7.9M -6.3%	$8.4M

AI Insight: AMS Financial Trends

AMS remains unprofitable with deteriorating leverage; debt surged 89% from Q2 2024 to Q1 2026 while revenue flatlined and operating income stayed negative.

• Revenue volatile between $6M–$9M; Q1 2026 at $7M, below Q4 2024 peak of $9M. No growth trajectory evident.

• Operating income consistently negative since Q2 2024, ranging $0M to $-2M. No path to profitability visible.

• Total debt increased 89% from $18M (Q2 2024) to $34M (Q1 2026); equity contracted from $27M to $24M.

⚠ Debt-to-equity ratio rose from 0.67x to 1.42x in 8 quarters. Leverage now exceeds equity base.

⚠ Operating cash flow erratic (range $-1M to $3M); Q1 2026 showed $2M but prior quarter was $-1M.

AI Insight: AMS Ratio Trends

AMS remains deeply unprofitable across all metrics; operating margin deteriorated from -4.8% in Q3 2025 to -13.0% in Q1 2026, with leverage rising to 1.43x D/E.

• Operating margin swung sharply negative: -4.8% in Q3 2025 improved to -13.0% in Q1 2026, signaling operational stress.

• All profitability metrics remain negative; TTM net margin -5.3%, ROE -6.6%, ROIC -5.6% with no path to positive earnings visible.

• Debt-to-equity rose from 1.13x in Q3 2025 to 1.43x in Q1 2026, approaching TTM peak of 1.43x amid ongoing losses.

⚠ Q3 2025 showed near-breakeven metrics (-0.2% NPM, -0.3% ROE); Q4 2025 and Q1 2026 deterioration indicates unsustainable seasonality or structural decline.

⚠ High leverage with negative ROIC suggests capital is being destroyed; sustainability of current financial structure at risk.

Get alerted when AMS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for AMERICAN SHARED HOSPITAL SERVICES including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of AMS

DIMENSIONAL FUND ADVISORS LP
$297.4K205,120 sh
Corient Private Wealth LLC
$232.8K160,559 sh
VANGUARD CAPITAL MANAGEMENT LLC
$222.9K153,737 sh
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$131.7K90,820 sh
LPL Financial LLC
$110.7K76,366 sh
RENAISSANCE TECHNOLOGIES LLC
$71.3K49,200 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$61.4K42,314 sh
DRW Securities, LLC
$47.7K32,889 sh
GEODE CAPITAL MANAGEMENT, LLC
$47.3K32,588 sh
JAMES INVESTMENT RESEARCH, INC.
$43.1K29,725 sh

Fund	Value	Shares
DIMENSIONAL FUND ADVISORS LP	$297.4K	205,120
Corient Private Wealth LLC	$232.8K	160,559
VANGUARD CAPITAL MANAGEMENT LLC	$222.9K	153,737
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$131.7K	90,820
LPL Financial LLC	$110.7K	76,366
RENAISSANCE TECHNOLOGIES LLC	$71.3K	49,200
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$61.4K	42,314
DRW Securities, LLC	$47.7K	32,889
GEODE CAPITAL MANAGEMENT, LLC	$47.3K	32,588
JAMES INVESTMENT RESEARCH, INC.	$43.1K	29,725

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put AMS on your watchlist

Track score changes the day AMERICAN SHARED HOSPITAL SERVICES files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is AMS a good stock to buy?

13F Pro's AI-powered analysis of AMERICAN SHARED HOSPITAL SERVICES (AMS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMS are available on the AMS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AMERICAN SHARED HOSPITAL SERVICES's investment landscape.